The Clorox Company (NYSE:CLX) Shares Bought by GAMMA Investing LLC

GAMMA Investing LLC raised its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 11,108.0% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 349,130 shares of the company's stock after buying an additional 346,015 shares during the quarter. GAMMA Investing LLC owned about 0.28% of Clorox worth $51,409,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Redwood Park Advisors LLC bought a new stake in Clorox in the 4th quarter worth approximately $26,000. Millstone Evans Group LLC bought a new position in shares of Clorox during the fourth quarter valued at approximately $31,000. Wood Tarver Financial Group LLC bought a new position in shares of Clorox during the fourth quarter valued at approximately $31,000. Asset Planning Inc bought a new position in shares of Clorox during the fourth quarter valued at approximately $32,000. Finally, GKV Capital Management Co. Inc. purchased a new stake in Clorox in the fourth quarter worth $32,000. Institutional investors own 78.53% of the company's stock.

Clorox Stock Performance

Shares of CLX stock traded down $0.32 during trading hours on Wednesday, reaching $129.77. 1,155,297 shares of the company's stock were exchanged, compared to its average volume of 1,342,740. The Clorox Company has a 1 year low of $129.03 and a 1 year high of $171.37. The company has a market cap of $15.99 billion, a P/E ratio of 35.46, a price-to-earnings-growth ratio of 2.62 and a beta of 0.60. The company's 50 day moving average is $137.73 and its two-hundred day moving average is $150.63. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The company reported $1.45 earnings per share for the quarter, missing the consensus estimate of $1.57 by ($0.12). Clorox had a return on equity of 316.87% and a net margin of 6.38%. The company had revenue of $1.67 billion for the quarter, compared to analysts' expectations of $1.74 billion. During the same period in the previous year, the business posted $1.71 EPS. The business's quarterly revenue was down 8.0% on a year-over-year basis. Equities research analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently commented on CLX. JPMorgan Chase & Co. dropped their price objective on Clorox from $151.00 to $144.00 and set a "neutral" rating on the stock in a research report on Tuesday, May 6th. Morgan Stanley decreased their price objective on Clorox from $165.00 to $150.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 6th. Citigroup decreased their price objective on Clorox from $165.00 to $150.00 and set a "neutral" rating on the stock in a research note on Monday, April 14th. Evercore ISI set a $140.00 price objective on Clorox and gave the stock an "underperform" rating in a research note on Tuesday, May 6th. Finally, DA Davidson decreased their price target on Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a report on Wednesday, February 5th. Three investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, Clorox presently has a consensus rating of "Hold" and an average price target of $151.23.

Insiders Place Their Bets

In other Clorox news, Director Pierre R. Breber acquired 4,000 shares of Clorox stock in a transaction dated Wednesday, May 7th. The stock was acquired at an average cost of $136.57 per share, for a total transaction of $546,280.00. Following the completion of the transaction, the director now owns 4,000 shares in the company, valued at approximately $546,280. This represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.57% of the stock is currently owned by insiders.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.